Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Nextleaf Solutions (OILS) has completed the acquisition of IP relating to the nano-delivery of cannabinoids in cannabis-infused edibles and drinks
  • The technology will allow consumers to feel the desired effects of products in less than 10 minutes
  • Total consideration of 937,500 common shares in Nextleaf will be issued to the developers of the technology
  • Nextleaf shares are currently up 1.56 per cent to C$0.32, with a market cap of C$35.14 million

Nextleaf Solutions (OILS) has completed the acquisition of intellectual property related to the nano-delivery of cannabinoids in CBD and THC-based beverages.

The proprietary delivery system, which has been 10 years in the making, increases the speed at which the effects of THC, CBD and other cannabinoids are felt by consumers of cannabis-infused edibles and beverages.

In most cases, cannabis-infused products take anywhere from 30 to 60 minutes for the consumer to feel the desired effects.

“The intellectual property we’ve acquired allows consumers to feel the desired effect from cannabinoid infused drinks and edibles in under 10 minutes,” said Nextleaf CEO, Paul Pedersen.

“We are excited to commercialize this game changing technology by supplying water-soluble THC and CBD solutions through our private label program.” 

The company currently has a patent allowance success rate of 100 per cent, compared to the wider cannabis industry’s rate of just 30 per cent, and plans to seek protection for the newly acquired intellectual property.

“For the past three years our team has focused on developing efficient, patented extraction technology to put distilled cannabinoids into IP-protected delivery formats such as beverages and edibles,” continued Pedersen. 

A team of chemical engineers, who were the original developers of the cannabinoid delivery technology, will be issued 937,500 common shares in Nextleaf as consideration for the deal.

The issuance of the shares, however, will be dependent on the completion of the second and final milestones as outlined in the agreement.

Nextleaf shares are currently up 1.56 per cent to C$0.32, with a market cap of C$35.14 million.

More From The Market Herald

" Shoppers Drug Mart exits medical cannabis business

Avicanna has signed a definitive agreement to acquire Shoppers Drug Mart’s medical cannabis business.

" The Market Herald’s Weekly Cannabis Report – May 26, 2023

Tilray Brands Inc. (TSX:TLRY) has received authorization from Italy’s Ministry of Health to distribute three new medical cannabis compounds.

" The Market Herald’s Weekly Cannabis Report – May 19, 2023

PharmaCielo (TSXV:PCLO) has made an initial shipment of CBD Isolate to a specialty biotechnology company based in South Africa.

" This cannabis brand is growing across popular categories

Lifeist’s (TSXV:LFST) subsidiary, CannMart Inc. reported strong sales growth and product breadth expansion.